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BACKGROUND: Exposure to the environmental endocrine disruptor bisphenol A (BPA) is ubiquitous and associated with the increased risk of diabetes
and obesity. However, the underlying mechanisms remain unknown. We recently demonstrated that perinatal BPA exposure is associated with higher
body fat, impaired glucose tolerance, and reduced insulin secretion in ﬁrst- (F1) and second-generation (F2) C57BL/6J male mice oﬀspring.
OBJECTIVE:We sought to determine the multigenerational eﬀects of maternal bisphenol A exposure on mouse pancreatic islets.
METHODS: Cellular and molecular mechanisms underlying these persistent changes were determined in F1 and F2 adult oﬀspring of F0 mothers
exposed to two relevant human exposure levels of BPA (10 lg=kg=d-LowerB and 10 mg=kg=d-UpperB).
RESULTS: Both doses of BPA signiﬁcantly impaired insulin secretion in male but not female F1 and F2 oﬀspring. Surprisingly, LowerB and UpperB
induced islet inﬂammation in male F1 oﬀspring that persisted into the next generation. We also observed dose-speciﬁc eﬀects of BPA on islets in
males. UpperB exposure impaired mitochondrial function, whereas LowerB exposure signiﬁcantly reduced b-cell mass and increased b-cell death that
persisted in the F2 generation. Transcriptome analyses supported these physiologic ﬁndings and there were signiﬁcant dose-speciﬁc changes in the
expression of genes regulating inﬂammation and mitochondrial function. Previously we observed increased expression of the critically important
b-cell gene, Igf2 in whole F1 embryos. Surprisingly, increased Igf2 expression persisted in the islets of male F1 and F2 oﬀspring and was associated
with altered DNA methylation.
CONCLUSION: These ﬁndings demonstrate that maternal BPA exposure has dose- and sex-speciﬁc eﬀects on pancreatic islets of adult F1 and F2 mice
oﬀspring. The transmission of these changes across multiple generations may involve either mitochondrial dysfunction and/or epigenetic modiﬁca-
tions. https://doi.org/10.1289/EHP1674
Introduction
Over the past decade, the incidence of diabetes has increased
dramatically. The WHO estimates mortality due to diabetes to
increase by 50% in the next 10 y, making it a major cause of death
by 2030 and placing a substantial economic burden on the health
care system globally (Mathers and Loncar 2006; American Diabetes
Association 2013). Therefore, understanding the underlying factors
of this global epidemic is critical. It has been well established that
factors such as food intake and sedentary lifestyle signiﬁcantly
inﬂuence the incidence of diabetes. Although these are important
factors, changes in our lifestyle have also increased our exposure
to a variety of synthetic chemicals that are linked to various dis-
eases such as diabetes and obesity in experimental models and
human epidemiological studies (Alonso-Magdalena et al. 2015b;
Jašarević et al. 2011; Lang et al. 2008; Newbold et al. 2008).
Bisphenol A (BPA) is one such synthetic chemical to which
we are ubiquitously exposed through food, drink, and skin con-
tact (Stahlhut et al. 2009). Detectable amounts of BPA are found
in urine samples of populations from around the world (Nahar
et al. 2012; Stahlhut et al. 2009; Zhang et al. 2011). Exposure to
BPA has been associated with prediabetes and type 2 diabetes in
human cross sectional (Aekplakorn et al. 2015; Ahmadkhaniha
et al. 2014; Sabanayagam et al. 2013; Shankar and Teppala 2011)
and longitudinal studies (Sun et al. 2014). Such associations have
been further conﬁrmed using animal models of exposure during
adulthood (Alonso-Magdalena et al. 2006; Batista et al. 2012).
The pancreas undergoes substantial remodeling during late
gestation and early neonatal life. This involves formation of new
b cells by diﬀerentiation of precursor cells during late gestation
(Hellerstrom et al. 1988) followed by substantial remodeling,
including high rates of replication and cell death in the neonatal
period (Finegood et al. 1995; Scaglia et al. 1995, 1997; Swenne
1983). The b-cell replication rate gradually declines (Finegood
et al. 1995; Swenne 1983), and post-weaning b-cell turnover is
regulated by b-cell death and very slow rates of replication
(Bouwens and Rooman 2005; Scaglia et al. 1995). An exposure
to synthetic chemicals such as BPA during this vulnerable period
is even more concerning because of the potential to not only alter
normal fetal development, but also to impact later life health and
disease. Furthermore, the fetus is particularly vulnerable to the
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eﬀects of BPA because the degradation pathways are immature,
leading to accumulation and high levels of BPA (Takahashi and
Oishi 2000; Zalko et al. 2003). Consistent with this ﬁnding, our
previous studies and studies by others have shown that perinatal
exposure to BPA leads to metabolic defects in oﬀspring (Alonso-
Magdalena et al. 2010; Angle et al. 2013; Mackay et al. 2013;
van Esterik et al. 2014; Wei et al. 2011) and in subsequent gener-
ation oﬀspring (Li et al. 2014; Susiarjo et al. 2015). We recently
demonstrated that maternal exposure via maternal transmission
to relevant human exposure levels of BPA, 10 lg=kg=d
(LowerB) or 10 mg=kg=d (UpperB) prior to conception and
through lactation is associated with higher body fat, impaired
glucose tolerance, and reduced glucose-stimulated insulin secre-
tion (GSIS) across two generations in adult male mice oﬀspring
(Susiarjo et al. 2015). Despite our expanding knowledge on the
association of BPA with increased risk of diabetes, the mecha-
nisms underlying this link remain to be elucidated.
In the current study, we tested the hypothesis that early devel-
opmental exposure to BPA alters key aspects of b-cell function
leading to impaired insulin secretion in the oﬀspring and that
these changes would persist across two generations.
Materials and Methods
Experimental Paradigm
The animal work was conducted with the approval of the
University of Pennsylvania Institutional Animal Care and Use
Committee. All animals were treated humanely and with regard
for alleviation of suﬀering. The animals used in this study were
generated using the same procedure as described previously
(Susiarjo et al. 2015). (See Figure S1 for the experimental
design.) C57BL/6 virgin female mice (F0) were randomly
assigned to the following three diets from 2 wk prior to mating
until weaning: 10 lg=kg=d (LowerB), 10 mg=kg=d (UpperB)
BPA, and 7% corn oil (Control). These doses were selected based
on our previous study (Susiarjo et al. 2013), where we reported
that the levels of unconjugated BPA in serum from pregnant
mice were representative of human exposure levels (Susiarjo
et al. 2013). The oﬀspring after weaning, and the subsequent
generations, were maintained on the control diet. All terminal
tests were performed in 16- to 21-wk-old ﬁrst- (F1) and second-
generation (F2) adult oﬀspring, other than cell viability assays
that were performed in 8- to 10-wk-old oﬀspring. The experi-
ments were blinded, where possible (e.g., immunoﬂuorescence
staining and Luminex assay). To account for robustness of the
studied outcomes and cohort consistency in our paradigm, the
end points measured were from animals generated across multi-
ple cohorts studied in two diﬀerent animal care facilities, with a
control group included in all cohorts (see Figure S2). For most
assessments, n=5− 6 litters per group were used other than for
extensive cytokine assays, RNA seq, islet perifusion ramps, and
islet cytosolic calcium determination where mice from n=3–4
litters per group were used. Metabolic studies including GSIS
and a-ketoisocaproate ramp studies were performed in both male
and female oﬀspring. However, because no metabolic phenotype
was observed in female oﬀspring across two generations, all
mechanistic studies were performed on males only. Females were
only additionally assessed for transcriptomic diﬀerences via RNA
seq to determine if there were additional pathways we did not
anticipate that might be disrupted in the islet.
Islet Isolation
F1 and F2 adult mice pancreata were perfused with Hanks’ bal-
anced salt solution (Life Technologies) supplemented with 2.5%
bovine serum albumin (BSA) (wt/vol; Sigma), 0:35 g=L NaHCO3
(Sigma), and 2 mg=mL Collagenase P (Roche); excised; and incu-
bated at 37°C for 10–15 min. After digestion, islets were washed
and then puriﬁed using a Histopaque 10771 and Histopaque 11191
(Sigma) gradient. To provide suﬃcient starting material for
Oroboros, RNA and DNA extraction, islets had to be pooled from
2–3 male mice (either male or female for RNA) from within the
same litter. This helped minimize the within-litter variability,
which is not uncommon in endocrine-disruptor models. For
remaining evaluations, one mouse per litter was randomly selected
as a litter representative. More than one islet-speciﬁc end point
was determined for each litter, where possible (see Figure S2). A
combination of studied outcomes from pooled as well as from an
individual animal from each litter helped in assessing both nonran-
dom and stochastic biological changes.
Insulin Measurement and Islet Perifusion Study
Isolation of pancreatic islets, perifusion, and insulin assays were
performed as previously described (Li et al. 2010). In brief, islets
were isolated by collagenase digestion and cultured with 10mM
glucose in RPMI 1640 medium (Sigma) for 2 d. Islets were peri-
fused with a Krebs-Ringer bicarbonate buﬀer containing 0.25%
BSA at a ﬂow rate of 1 mL=min. Ramps at increments of
0:5mM=min for glucose, and 0:3mM=min for a-ketoisocaproate
were performed. Thirty millimolar potassium chloride was used
to determine maximum insulin release. Insulin was measured in
the perfusates following the ramp studies, as well as in the lysates
from freshly isolated islets by homogeneous time-resolved ﬂuo-
rescence technology (Cisbio Kit).
Islet Mitochondrial Function by High-Resolution
Respirometry
A high-resolution respirometry was performed in ∼ 800 overnight-
cultured intact islets using Oxygraph-2K (Oroboros Instruments,
Innsbruck, Austria). The intact islets were diluted with RPMI
and 1–1:5million cells/chamber were added to each chamber of
the Oxygraph-2K in 2 mL volume per chamber. For each experi-
ment, two Oroboros machines were used at a time, and in each
machine islets from one of the BPA-exposed groups and Control
were run in parallel. The use of chambers for a particular treat-
ment and control was switched between the experiments to avoid
any bias due to chamber diﬀerences. The experiment was per-
formed at 37°C with constant magnetic stirring set at 750 rpm.
After the addition of intact islets into the oxygraph chambers, the
basal respiration referred to as the ROUTINE state was measured
when a stable oxygen ﬂux was reached. Following this step, inhib-
itors for the diﬀerent mitochondrial respiratory complexes were
added and oxygen consumption of mitochondria was measured
according to established protocol published previously (Zhang
et al. 2013). The inhibitors were added in the following order: oli-
gomycin (3 lM) (Sigma), to inhibit complex V (to assess nonmi-
tochondrial respiratory capacity or proton LEAK rate), carbonyl
cyanide-p-triﬂuoro-methoxyphenylhydrazone (FCCP) (Sigma)
uncoupler with stepwise titration in 0:5-to 1:5-lM increments [to
assess maximal electron transport system respiratory capacity rate
(ETS)]. Rotenone (Sigma) was added in a 0:5-lM ﬁnal concentra-
tion to inhibit complex I, and antimycin A (Sigma) in a 2:5-lM
ﬁnal concentration was added last to inhibit complex III. Data was
analyzed using DatLab4 and DatLab6 (Oroboros, Austria) soft-
ware, and normalized to the total DNA concentration.
Islet Cytosolic Calcium Levels
In isolated islets, cytosolic calcium ½Ca2+ i responses were
measured by dual-wavelength ﬂuorescence microscopy using
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Fura-2AM (Life Technologies) as a calcium indicator, and cal-
cium dynamics were measured with the Zeiss AxioVision system
(Carl Zeiss Microscopy, Thornwood, NY) (Li et al. 2013).
Histology
Pancreata were excised, and ﬁxed in 10% formalin (pH 7.0) for 48
h at room temperature, and embedded in paraﬃn (Tissue-Tek,
4,583). Six sections of 5 lm thickness, 100 lm apart were
selected for immunohistochemical (IHC) and immunoﬂuorescence
(IF) staining per animal. Prior to any antigen-speciﬁc staining, sub-
sets of sections from each animal were H & E stained, and assessed
by an independent, blinded pathologist for section quality (see
Figure S3). All slides were pretreated in an antigen retriever with ei-
ther 0:01 M citrate buﬀer pH 7.6 (Vector Labs), or pH9 Retrieval
Solution (DAKO), and blocked using 2% fetal bovine serum.
For immunohistochemical staining, slides were incubated in
primary F4/80 antibody (Invitrogen) 1:50 overnight at 4°C, or
Figure 1.Mitochondrial driven insulin secretion in islets of F1 and F2 adult male oﬀspring: (A, C) F1 and (B, D) F2 adult male oﬀspring. The maximal KIC-
stimulated insulin release was calculated as the insulin area under the curve for 15mM KIC. Data are individual litter data (one animal per litter), presented as
mean+SEM, and analyzed using Dunnett’s test. p-Values are relative to Control. Note: KCL, potassium chloride; KIC, a-ketoisocaproate.
Figure 2. Glucose-stimulated and mitochondrial associated insulin secretion in islets of F1 and F2 adult female oﬀspring: (A–B, E–F) F1, and (C–D, G–H) F2
adult female oﬀspring. The maximal glucose- and KIC-stimulated insulin release was calculated as the insulin area under the curve for 25mM glucose or
15mM KIC, respectively. Data are individual litter data (one animal per litter), presented as mean+SEM, and analyzed using Dunnett’s test. p-Values are rela-
tive to Control. Note: KCL, potassium chloride; KIC, a-ketoisocaproate.
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CD3 antibody (Santa Cruz) 1:250 for 2 h at room temperature.
Secondary anti-rat IgG (Vector Lab) and anti-goat IgG (Vector
Lab) antibodies were used in a 1:200 dilution for 30 min at room
temperature.
For immunoﬂuorescence staining, slides were incubated with
antibodies against insulin (Abcam) 1:50 for 16 h at 4°C, glucagon
(Biogenix) 1:50 for 1 h at room temperature, and somatostatin
(Biorad) 1:50 for 1 h at room temperature. Secondary antibodies
Alexa Fluor® 594 anti-guinea pig (Invitrogen), Alexa Fluor® 647
anti-rabbit (Invitrogen), and Alexa Fluor® 488 anti-rat (Invitrogen)
1:200 were applied for 1 h at room temperature in the dark. The
nuclei were stained using DAPI (Sigma). To quantify staining,
slides were digitally scanned at 20× magniﬁcation on an Aperio
Scanscope CS-O (brightﬁeld) and Scanscope IF (ﬂuorescent)
(Leica Biosystems). Nonﬂuorescent staining was analyzed by
ImageScope v12.2.2.5015 (Leica Biosystems) using Aperio-
Color Deconvolution v9.1 algorithm. The area of CD3 and F4/80
staining was calculated within islets, pancreatic lymph nodes,
and non-islet tissue by multiplying percent positive staining with
total stained area and the product was normalized to total analy-
sis area. Fluorescent staining was analyzed by HALO v2.0.1018
(Indica Lab) using Indica Labs Area Quantiﬁcation FL v1.0 algo-
rithm. Islets were identiﬁed as insulin surrounded by glucagon
and somatostatin staining. Beta-, alpha-, and delta-cell mass was
calculated by multiplying the average insulin, glucagon, and so-
matostatin stained area, respectively, within each islet relative to
the total area scanned with the pancreatic weight and then cor-
rected for body weight measured at tissue harvest.
Cytokine Measurement
The cytokine and chemokine panels were measured in pancreatic
lysates by mouse Cytokine/Chemokine Luminex 25plex Assay with
a detection limit of 3:2 pg=mL to 10,000 pg=mL (EMD Millipore),
as described previously (Jaeckle Santos et al. 2014). Interleukin-6
(IL6) and monocyte chemoattractant protein-1 (MCP1) levels
were conﬁrmed using mouse ELISA kits (Thermo Fisher).
Cytokine levels were normalized to total protein concentration
measured by BCA (bicinchoninic acid) assay (Pierce).
RNA Sequencing
Total RNA was extracted from pooled islets using the Trizol and
Qiagen RNeasy mini kit following the manufacturer’s instruc-
tions. RNA integrity was determined using Agilent RNA 6000
Nano Kit and samples with an RNA integrity number of >7 were
used to make RNA libraries. TruSeq Illumina RNA libraries
were sequenced using the high-throughput whole transcriptome
next generation sequencing to generate 60–80 million reads per
sample. Fastq data was processed with HTSeq-count v0.6.1, and
aligned using STAR v2.4.0 software. The edgeR v3.12.1 was
used to ﬁnd diﬀerentially expressed genes via log2FC and false
discovery rate values. Functional analyses were conducted using
Figure 3. Basal and maximal mitochondrial oxygen consumption in islets of F1 and F2 adult male oﬀspring: (A–B) F1, and (C–D) F2 adult male oﬀspring.
Data are individual litter data (islets pooled from 2–3 males from the same litter) with mean superimposed. Data were analyzed using Dunnett’s test. p-values
are relative to Control. Oxygen ﬂow per cell at: ROUTINE, i.e., basal state of cell respiration; electron transport system [ETS; uncoupled; carbonyl cyanide-p-
triﬂuoro-methoxyphenylhydrazone (FCCP)]; and residual oxygen consumption (rox; rotenone, antimycin A).
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Ingenuity Pathway Analysis (Ingenuity Systems; http://www.
ingenuity.com).
Islet mRNA Expression Analysis
RNA extracted from pooled islets with an RNA integrity number
of >7 were used for gene expression analysis. Using Biorad
iScript kit, cDNA was subsequently generated. Real-time poly-
merase chain reaction (PCR) was performed using TaqMan Gene
expression assay in Applied Biosystems 7900HT Fast Real-Time
PCR System. F1 data was normalized to Rpl19 and Beta actin,
and F2 data was normalized to Rpl19 and Cyclophilin A (Ppia).
The primers and probes are listed in Table S1.
Islet Protein Expression Analysis
The levels of estrogen receptor alpha (ESR1) and uncoupling protein
2 (UCP2) proteins were measured in lysates by using mouse ESR1
(Aviva Systems Biology), and mouse UCP2-Ab (MyBioSource)
ELISA kits, following the manufacturer’s instructions. Target
protein levels were normalized to total protein concentration
measured by BCA assay (Pierce).
Islet DNAMethylation Analysis
DNA was extracted from pooled islets using the QIAmp DNA
Mini Kit (Qiagen), and 1 lg of DNA was bisulﬁte treated using
the EpiTect Bisulﬁte Kit (Qiagen) following the manufacturer’s
protocol. Pyrosequencing was conducted to measure the methyla-
tion status of the promoter region of the Igf2 DMR1 (chr7:
149,851,180–149,851,655; NCBI37/MM9) and H19/Igf2 ICR
(chr7: 149,767,599–149,767,819; NCBI37/MM9), and exon A
and exon C of the Esr1 gene as described previously by Susiarjo
et al. (2013) and Kundakovic et al. (2013), respectively. Brieﬂy,
50 ng of puriﬁed bisulﬁte-treated DNA was ampliﬁed using a
PyroMark PCR kit (Qiagen) and primers speciﬁc for the Igf2
DMR1, H19/Igf2 ICR, and exon A and exon C of the Esr1gene
(see Table S2). Ten microliters of the biotinylated PCR product
was used for each sequencing assay and sequenced using a
PyroMark Q96MD (Qiagen) pyrosequencer and PyroMark Gold
96 reagents kit (Qiagen) and speciﬁc pyrosequencing primers
(see Table S2). Percent methylation levels of CpG sites were
quantiﬁed using Qiagen’s Pyro Q-CpG software.
Islet Viability Assays
Lysates from freshly isolated islets from 8- to 10-wk-old F1 and
F2 mice were assessed for apoptosis using the caspase 3 activity
ﬂuorometric assay (Abcam), BCL2 levels using the mouse BCL2
ELISA kit (LS Bio), and phospho-AKT (pSer473) and total AKT
levels using the AKT (pSer473) + total AKT ELISA kit (Abcam)
following the manufacturer’s instructions.
Statistical Analysis
For comparison between LowerB with Control, and UpperB with
Control, we used Dunnett’s test, which accounts for multiple test-
ing. For pyrosequencing data, using Dunnett’s test, we statisti-
cally analyzed methylation levels at individual CpG sites as well
as mean methylation across all CpG sites for our two BPA treat-
ment groups relative to Control. In addition, we performed multi-
variate analyses of variance followed by repeated measures
response design to determine a) methylation levels diﬀer between
the groups, b) methylation levels diﬀer between CpG sites, and c)
diﬀerences in methylation levels across CpG sites interact with
study groups. Nonparametric data were log-transformed to ap-
proximate a standard distribution, where required. All values are
presented as mean±SEM. A p-value of <0:05 was considered
signiﬁcant. All data were analyzed using JMP and Prism analysis
software.
Results
Dose- and Sex-Specific Effects of Maternal BPA
Exposure on Islet Mitochondrial Function in F1 and F2
Adult Offspring
Using our mouse model of BPA exposure, we previously
observed impaired GSIS in the F1 and F2 generation adult male
oﬀspring of mothers (F0) exposed to 10 lg=kg=d (LowerB) or
10 mg=kg=d (UpperB) relative to Controls (7% corn oil diet)
(Susiarjo et al. 2015). Nutrient-induced insulin secretion requires
ATP production from mitochondria (Antinozzi et al. 2002;
Ortsäter et al. 2002). Mitochondrial dysfunction has been associ-
ated with b-cell failure in islets of intrauterine growth-restricted
rats (Simmons et al. 2005). To assess whether impaired GSIS
in F1 and F2 adult male oﬀspring is due to altered mitochon-
drial driven insulin secretion, we measured insulin secretion
in response to a-ketoisocaproate, a substrate metabolized in
mitochondria. Surprisingly, a-ketoisocaproate–stimulated insulin
secretion in the islets of F1 and F2 LowerB males was compara-
ble to levels in Controls. However, it trended to be reduced in F1
and F2 UpperB males relative to Controls (Figure 1), thus reﬂect-
ing an abnormal mitochondrial phenotype in islets of UpperB
males. We saw no diﬀerences in glucose or a-ketoisocaproate–
stimulated insulin secretion in LowerB or UpperB F1 or F2
females compared with Control females (Figure 2). Therefore,
all further studies were conducted exclusively in adult male
oﬀspring.
Table 1.mRNA Levels in islets of F1 and F2 Lower BPA and Upper BPA
male mice.
Gene Lower BPA (95% CI) Upper BPA (95% CI)
Igf2
F1 1.67 (1.20, 2.31)* 2.19 (1.71, 2.79)*
F2 1.48 (1.03, 2.30)* 1.23 (1.13, 1.34)*
Ucp2
F1 1.51 (1.03, 2.21)* 2.54 (1.52, 3.24)*
F2 2.05 (1.78, 2.36)* 1.74 (1.05, 3.08)*
Ogdh
F1 0.97 (0.72, 1.29) 1.40 (0.96, 2.03)
F2 1.20 (1.18, 1.22)* 1.32 (0.97, 1.80)
Esr1
F1 0.70 (0.53, 0.93)* 0.88 (0.82, 0.94)*
F2 0.38 (0.18, 0.84)* 0.48 (0.24, 0.97)*
Pdx1
F1 1.32 (0.82, 2.11) 1.72 (1.11, 2.64)*
F2 1.31 (0.86, 2.00) 1.21 (0.48, 3.03)
Igf1
F1 1.05 (0.95, 1.15) 1.55 (1.10, 2.19)*
F2 1.08 (0.94, 1.25) 1.23 (1.13, 1.34)*
Hnf1a
F1 1.06 (0.89, 1.27) 1.43 (1.30, 1.59)*
F2 1.00 (0.85, 1.17) 1.21 (0.94, 1.57)
Kcnj11
F1 1.54 (0.70, 3.41) 0.94 (0.45, 1.99)
F2 1.56 (0.92, 2.64) 1.06 (0.36, 3.12)
Abcc8
F1 1.48 (0.75, 2.92) 0.99 (0.55, 1.78)
F2 1.94 (1.48, 2.54)* 1.46 (0.63, 3.37)
Snap25
F1 1.02 (0.43, 2.38) 0.71 (0.30, 1.65)
F2 1.46 (0.66, 3.26) 1.17 (0.38, 3.61)
Note: Data were normalized to Rpl19 and Beta actin or Ppia mRNA levels and
expressed as fold change relative to Controls (where Control is set at 1.0) with 95% con-
fidence intervals (CI) in islets of F1 and F2 Lower BPA (10 lg=kg=d) and Upper BPA
(10 mg=kg=d) male mice. n=5 litters per group; islets pooled from 2–3 male mice per
litter. *p<0:05 vs. Controls.
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To determine whether the phenotype in males was associated
with mitochondrial dysfunction, we performed high-resolution
respirometry to assess oxygen consumption in intact islet mitochon-
dria using Oroboros. Consistent with the above results, we did not
see any diﬀerence in oxygen consumption in the intact islets of F1
and F2 LowerB males, but did observe reduced basal and maximal
oxygen consumption in the intact islets of F1 and F2 UpperB males
relative to Controls (Figure 3). These results are consistent with
abnormal mitochondrial function in the islets of the UpperB males,
and the reduction in GSIS in F1 and F2 LowerB males may be due
to a factor other than a mitochondrial defect.
Others have shown that BPA exposure alters expression of
key mitochondrial genes such as oxoglutarate dehydrogenase
(Ogdh) and uncoupling protein 2 (Ucp2) in rodent islets (Wei
et al. 2011; Song et al. 2012). Because we observed mitochon-
drial dysfunction in the current study, we sought to determine
whether these previously demonstrated mitochondrial targets of
BPA are aﬀected. OGDH is the rate-limiting enzyme in the tricar-
boxylic acid (TCA) cycle, which plays a key role in mitochon-
drial function. UCP2 is a member of the mitochondrial carrier
family whose loss of function mutation can cause hyperinsulin-
ism, whereas its overexpression is associated with the eﬄux
of TCA cycle intermediates out of the mitochondria, thereby
reducing acetyl-CoA–oxidizing substrates in the mitochondria
(González-Barroso et al. 2008; Vozza et al. 2014). Ogdh expres-
sion was only mildly increased in LowerB F2 males compared
with Controls (Table 1). In contrast, Ucp2 mRNA levels were
signiﬁcantly increased in LowerB and UpperB F1 and F2 males
compared with Controls (Table 1). The changes in mitochondrial
gene expression are consistent with UpperB F1 and F2 mitochon-
drial impairment, although these changes did not translate to
statistically signiﬁcant diﬀerences in protein expression levels.
F1 and F2 UpperB males (F1 4:0× 10−4 ± 1:0× 10−5ng=lg,
p=0:43; F2 6:3× 10−4 ± 1:7× 10−5ng= lg, p=0:74; n=5) and
LowerB males (F1 4:3× 10−4 ± 1:0× 10−5ng=lg, p=0:31; F2
6:1× 10−4 ± 1:7× 10−5ng=lg, p=0:80; n=5) had increased
UCP2 protein levels relative to Controls (F1 2:3× 10−4 ±
1:0× 10−5ng=lg; F2 4:7× 10−4 ± 1:7× 10−5ng=lg; n=5); how-
ever, these ﬁndings were not statistically signiﬁcant.
Dose-Specific Effects of Maternal BPA Exposure on b-cell
Mass in F1 and F2 Adult Male Offspring
An alternative hypothesis for reduced insulin secretion is that
BPA exposure is associated with a reduction in the number of
insulin-secreting cells. To determine whether reduced GSIS in
BPA-exposed F1 and F2 male oﬀspring is linked to reduced
b-cell mass, we stained pancreatic sections with anti-insulin, glu-
cagon and somatostatin antibodies to quantify b-cell, alpha-, and
delta-cell mass, respectively. F1 and F2 LowerB males had
reduced b-cell mass adjusted for body weight relative to Controls
(Figure 4). F1 and F2 UpperB and Control males had comparable
b-cell mass. Alpha-cell mass was similar among the F1 males,
but F2 LowerB males had a modest increase in alpha-cell mass
Figure 4. Beta cell mass of F1 and F2 adult male oﬀspring. Representative photomicrographs of pancreatic immunoﬂuorescent staining in (A–C) F1 and (D–F) F2
Control, LowerB, UpperB male mice. All images have insulin (red), glucagon (green), somatostatin (yellow), and DAPI (blue). Image magniﬁed 20× . Data are indi-
vidual litter data (one animal per litter) with mean superimposed from (G) F1 and (H) F2 males, analyzed by Dunnett’s test. p-Values are relative to Control.
Environmental Health Perspectives 097022-6
compared with Controls (see Figure S4). F1 and F2 LowerB and
UpperB had comparable delta mass as Controls (see Figure S4).
Thus, LowerB exposure speciﬁcally reduced b-cell mass across
two generations. We also measured pancreatic insulin content in
F1 and F2 males. UpperB had similar (F1 0:005±0:001 ng=lg,
p=0:97; F2 0:002±0:001 ng=lg, p=0:93; n=6), whereas
LowerB tended to have reduced insulin content (F1 0:002±
0:001 ng=lg, p=0:10; F2 0:001±0:0006 ng=lg, p=0:08;
n=6) relative to Controls (F1 0:004± 0:001 ng=lg; F2 0:003±
0:001 ng=lg; n=6).
We then examined possible mechanisms underlying the
reduction in b-cell mass. Caspase 3 activity, a marker of cell
death, was signiﬁcantly increased in islets of F1 and F2 LowerB
males but not in islets from UpperB males (Figure 5). BCL2, an
anti-apoptotic protein, did not diﬀer in F1or F2 LowerB com-
pared with Controls, but levels were increased in F1 UpperB
males relative to Controls (p=0:05; Figure 5). These changes
were associated with increased AKT phosphorylation in F1 and
F2 UpperB males relative to Controls. F1 and F2 LowerB males
had similar AKT phosphorylation as Controls (Figure 5). AKT
phosphorylation mediates the cell survival response by inhibiting
programed cell death (Reed and Paternostro 1999; Yao and
Cooper 1995). Thus, the UpperB group had increased AKT phos-
phorylation and no diﬀerence in islet cell death and b-cell mass,
whereas the LowerB group has increased islet cell death and
decreased b-cell mass across two generations.
Effects of Maternal BPA Exposure on Cytokine/
Chemokine Levels/Expression in Pancreata of F1 and F2
Adult Male Offspring
Several studies indicate that immune cells such as macrophages,
dendritic cells, and lymphocytes are present in islets and may play
an important role in normal islet development (Criscimanna et al.
2014; Geutskens et al. 2005; Jansen et al. 1993, 1994). In fact,
immune cell defects are linked to abnormal pancreatic develop-
ment and glucose homeostasis observed in athymic BALB/c nude
mice (Zeidler et al. 1991). To explore whether b-cell–speciﬁc
eﬀects of BPA are associated with a perturbed immune response,
we assessed the cytokine/chemokine proﬁle in pancreatic lysates
of F1 and F2 mice via a Luminex assay. Because diﬀerent immune
cell types produce and respond to diﬀerent cytokines/chemokines,
we have provided a list of these cell types in Table 2; see also
Tables S3 and S4. In F1 and F2 BPA-exposed versus Control
mice levels of the Th2 cytokine IL4 was reduced, but IL5 was ele-
vated, and pro-inﬂammatory cytokines IL6 and MCP1 were also
elevated (Table 2). Compared with Controls, F1 UpperB males
also had increased levels of G-CSF (granulocyte colony stimulat-
ing factor) and IL9 (see Table S3). IL17 was increased in F2
LowerB and UpperB males compared with Controls (Table 2).
The levels of other cytokines measured were comparable among
the three groups (see Tables S3 and S4). We validated the changes
in levels of key cytokines via ELISA and saw a similar trend of
increased cytokine levels of IL6 as well as signiﬁcantly increased
MCP1 levels in F1 and F2 LowerB and UpperB males relative to
Controls (Figure 6). This indicated that both doses of BPA
increased levels of pro-inﬂammatory cytokines in islets.
To verify the increased inﬂammatory phenotype in the pan-
creas of F1 and F2 BPA-exposed male mice, we immunostained
pancreatic sections with CD3, a marker for T lymphocytes,
and with F4/80, a marker for macrophages. We consistently
observed increased immunostaining of CD3 and F4/80 in the
islets of BPA-exposed F1 and F2 male mice compared with
Controls (Figure 7; Table 3). Thus, lower- and upper-dose BPA
exposure increased islet inﬂammation across two generations in
males. Taken together these ﬁndings indicate the recruitment of
macrophages and Th1 cells and, possibly, the recruitment of
neutrophils and activation of eosinophils in the pancreas.
Figure 5. Cell viability in islets of (A–C) F1 and (D–F) F2 male oﬀspring. Data are individual litter data (one animal per litter) with mean superimposed. Each
parameter is normalized to total protein concentration. Data were analyzed using Dunnett’s test performed on log-transformed data, where required (BCL2).
Note: RFU: relative ﬂuorescence unit. p-Values are relative to Control.
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Effects of Maternal BPA Exposure on Estrogen
Receptor Alpha Gene Expression in Islets of F1 and F2
Adult Male Offspring
The endocrine-disrupting actions of BPA are mediated by both
estrogen receptor dependent and independent pathways (Yoon
et al. 2014). Estrogen receptors (ESR1, or Esr1) are critically im-
portant to b-cell function and development (Tiano et al. 2011;
Yuchi et al. 2015) and have anti-inﬂammatory eﬀects in other
organs (Miller et al. 2012). We observed a signiﬁcant reduction
in mRNA expression of Esr1 in F1 and F2 LowerB and UpperB
males compared with Controls (Table 1). The Esr1 mRNA
changes in the LowerB group correlated with its protein expres-
sion, such that F1 and F2 LowerB males (F1 0:0002±0:001
ng=lg, p=0:09; F2 0:0001± 0:0003 ng=lg, p=0:09; n=5)
trended toward reduced ESR1 protein levels relative to Controls
(F1 0:0010±0:001 ng=lg; F2 0:0011± 0:0003 ng=lg; n=5);
however, F1 and F2 UpperB males (F1 0:0028± 0:001 ng=lg,
p=0:45; F2 0:0006± 0:0003 ng=lg, p=0:48; n=5) had ESR1
protein levels that were similar to those of Controls. BPA also
acts via the estrogen receptor beta (ESR2, or Esr2) and alters
stimulus-secretion coupling through its eﬀects on KATP chan-
nels and increasing glucose-stimulated ½Ca2+ i levels (Soriano
et al. 2009; Soriano et al. 2012). We did not observe any diﬀer-
ence in either mRNA levels of Esr2, KATP channels subunits
Kcnj11 and Abcc8, and Snap25, which mediate the calcium signal-
ing necessary for insulin secretion (Tables 1, 4, and 5), or in cyto-
solic Ca2+ levels in isolated islets of F1 and F2 LowerB and
UpperB adult males relative to Controls (see Figure S5). These
results demonstrate that the eﬀects of BPA exposure are mediated
preferentially by Esr1 and not Esr2 or targets of Esr2 in our study.
To determine whether BPA mediates change in islets Esr1
gene expression via DNA methylation as shown by others in
mouse (Kundakovic et al. 2013) and rat (Chang et al. 2016b)
brain, we assessed methylation status of 16 CpG sites across
untranslated exon A and exon C of Esr1 gene in islets. We
observed similar percent methylation at all ﬁve CpG sites of exon
C among the three groups (see Figure S6). We observed minimal
(4–5%), yet dose-speciﬁc, changes in the DNA methylation levels
of exon A in islets (Figure 8). F1 LowerB males trended toward
increased methylation levels at CpG sites 1 and 4, but F2
LowerB males had similar percent methylation level at all CpG
sites examined relative to Controls (Figure 8). The mean methyl-
ation across all CpG sites was also similar in F1 and F2 LowerB
males compared with Controls. In contrast, F2 UpperB males
trend toward increased methylation at CpG sites 3, 4, 5, and 10
and mean methylation across all CpG sites relative to Controls
(Figure 8). F1 UpperB males had similar methylation at individ-
ual CpG sites and mean methylation across all CpG sites relative
to Controls (Figure 8). On repeated measures analysis, we
observed signiﬁcant diﬀerences in methylation levels between
CpG sites (p<0:01); however, we saw no statistical diﬀerence in
methylation levels between the groups (p>0:1) or groups*CpG site
interaction (p>0:1) in islets of F1 and F2 males. Overall these ﬁnd-
ings indicate that BPA had minimal eﬀects on Esr1 methylation in
islets. It is possible that in addition to these minimal diﬀerences in
methylation levels, BPA may be mediating its eﬀect on Esr1 via
other regulatory mechanisms such as changes in chromatin acetyla-
tion/methylation levels. This requires further investigation.
Effects of Maternal BPA Exposure on Igf2 Expression and
DNAMethylation at Igf2 DMR1 in Islets of F1 and F2 Adult
Male Offspring
Insulin-like growth factor 2 (Igf2) plays a critical role in b-cell
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reported that Igf2 overexpression is associated with impaired glu-
cose tolerance (Höög et al. 1996; Susiarjo et al. 2015) and
impaired insulin secretion (Höög et al. 1996; Petrik et al. 1999).
Overexpression of Igf2 has also been reported to lead to b-cell dys-
function and marked morphological abnormalities of the islet
(Casellas et al. 2015). In previous studies, we observed an increased
expression of Igf2 in F1 and F2 upper dose BPA-exposed embryos
(Susiarjo et al. 2013). Thus, to determine whether Igf2 expression is
also increased postnatally in islets and whether these changes persist
into the next generation, we measured mRNA levels in islets from
F1 and F2 LowerB and UpperB groups by quantitative PCR
(qPCR). We found that Igf2 mRNA levels were signiﬁcantly
increased in F1 and F2 LowerB and UpperB males compared with
Controls (Table 1).
Previously, we determined that the increase in expression of
Igf2 in F1 and F2 islets in UpperB males was associated with
increased methylation at the Igf2 DMR1 (Susiarjo et al. 2013,
2015). Thus, we measured DNA methylation at H19/Igf2 imprint-
ing control region (ICR) and at Igf2 DMR1 in islets. F1 and F2
LowerB males had DNA methylation levels at Igf2 DMR1 and
H19/Igf2 ICR comparable with Controls (Figure 8; see also Figure
S6). In contrast, F1 UpperB males had increased methylation at
CpG site 1 and increased mean methylation, and F2 UpperB males
had increased methylation at CpG sites 1 and 2 as well as
increased mean methylation at Igf2 DMR1 relative to Controls
(Figure 8). Interestingly, on repeated measures, we observed dif-
ferences in methylation levels across CpG sites (F1 p<0:01; F2
p<0:01) and between groups (F1 p=0:04; F2 p=0:02), but no
statistical diﬀerence in groups*CpG site interaction (F1 p>0:1;
F2 p>0:1) at Igf2 DMR1. This analysis indicated that BPA aﬀects
methylation level at CpG sites but does not account for the methyl-
ation diﬀerences between CpG sites at Igf2 DMR1. However, we
saw no diﬀerence in methylation at H19/Igf2 ICR (see Figure S6),
suggesting that the increase in Igf2 expression in the islet results
from increased expression of the normally expressed paternal al-
lele and not loss of imprinting.
Effects of Maternal BPA Exposure on the Transcriptome of
F1 Adult Male and Female Offspring
To identify novel pathways and to determine whether changes in is-
let phenotypes in BPA-exposed mice are regulated at the gene
expression level, we conducted whole transcriptome analysis via
RNA sequencing in males and females. Consistent with our pheno-
typic data, we saw no diﬀerentially expressed genes in females
(Tables 6 and 7). Because of interanimal variability and the small
sample size, there were very few diﬀerentially expressed genes in
males when the analysis was corrected for multiple testing (q<
0:05). Interestingly, however, of the few diﬀerentially expressed
genes, there was minimal overlap between the LowerB and UpperB
males (Figure 9), consistent with the observed dose-speciﬁc pheno-
types. Moreover, qPCR of several key islet genes demonstrated ro-
bust diﬀerences between the groups despite higher q-values in the
RNAseq analysis (Tables 1, 4, 5). Thus, we performed ingenuity
pathway analysis on the RNAseq data using a p<0:05 and a fold
change of 1.5. Multiple genes associated with inﬂammation in
LowerB males, and both inﬂammation and mitochondrial function
including branched-chain a-keto acid dehydrogenase complex in
Figure 6. IL6, MCP1 levels in (A–B) F1 and (C–D) F2 adult male oﬀspring. Note: IL6, interleukin 6; MCPm: monocyte chemoattractant protein-1. Cytokine
levels for each sample were normalized to total protein concentration. Data are individual litter data (one animal per litter) with mean superimposed. Data were
analyzed by Dunnett’s test performed on log-transformed data, where required (F1 IL6, MCP1; F2 IL6). p-Values are relative to Control.
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UpperB males were altered compared with Controls, which is con-
sistent with the phenotypic data (Figure 9). Other pathways that are
critical for normal pancreatic development and regulation of insulin
secretion such as sonic hedgehog (Thomas et al. 2000) and
gap-junction signaling (Bavamian et al. 2007; Klee et al. 2011)
were altered in LowerB males, whereas pathways involved in
Figure 7. Representative photomicrographs of pancreatic immunohistochemical staining in F1 and F2 adult male oﬀspring: (A–H) F1 and (I–P) F2 Control,
LowerB, UpperB mice, and Positive Ctrl (internal Control—lymph node). Image magniﬁed 20× . Note: CD3, cluster of diﬀerentiation 3 (marker for T lympho-
cytes); F4/80, marker for macrophages. F1, n=6 litters per group (one animal per litter); F2, n=5 litters Control and UpperB, n=4 litters LowerB (one animal
per litter).












Area of percent positive CD3 staining in islets/total analysis area
F1 14:88± 5:57 29:33± 5:57 35:46± 5:57 0.04 0.02
F2 5:02± 2:89 5:90± 3:23 12:21± 2:89 0.51 0.06
Area of percent positive CD3 staining in pancreas excluding islets and
lymph nodes/total analysis area
F1 20:14± 3:43 24:67± 3:43 32:52± 3:43 0.42 0.04
F2 2:28± 1:10 6:40± 1:23 4:69± 1:10 0.04 0.18
Area of percent positive CD3 staining in pancreatic lymph nodes/total
analysis area
F1 23:81± 6:16 42:85± 6:16 44:98± 6:16 0.08 0.05
F2 17:99± 6:19 23:37± 6:92 15:47± 6:19 0.78 0.84
Area of percent positive F4/80 staining in islets/total analysis area
F1 1:91± 1:01 4:49± 1:01 5:94± 1:01 0.12 0.02
F2 3:52± 1:10 6:62± 1:23 7:66± 1:10 0.15 0.04
Area of percent positive F4/80 staining in pancreas excluding islets and
lymph nodes/total analysis area
F1 2:67± 1:62 7:51± 1:62 10:48± 1:62 0.09 0.01
F2 7:99± 1:74 12:87± 1:95 15:22± 1:74 0.10 0.03
Area of percent positive F4/80 staining in pancreatic lymph nodes/total
analysis area
F1 7:74± 3:34 11:81± 3:34 17:46± 3:34 0.60 0.10
F2 14:45± 4:17 12:23± 4:66 11:21± 4:17 0.94 0.81
Note: Data are normalized to total analysis area and presented as mean±SEM. Control, 7% corn oil diet; LowerB, Lower BPA (10 lg=kg=d); UpperB, Upper BPA (10 mg=kg=d).
n=4− 6 litters per group (one animal per litter). p-Values are from Dunnett’s test performed on log-transformed data, where required (F1 CD3 islets, F1 CD3 excluding islets and
lymph nodes, F2 CD3 islets, F2 F4/80 lymph nodes).
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inﬂammation and mitochondrial dysfunction such as G-protein cou-
ple receptor (Patial et al. 2009; Sorriento et al. 2013) and endoplas-
mic reticulum stress (Rocha et al. 2016) and signaling were altered
in UpperB males. Unexpectedly, there were minimal changes in
mRNA expression levels as determined by RNA Seq and qPCR of
other b-cell regulatory genes such as Pdx1, Igf1, and Hnf1a in BPA
groups compared with Controls (Tables 1, 4, and 5).
Discussion
We recently reported that early-life exposure to the endocrine-
disrupting chemical BPA in the mouse is associated with sex-
speciﬁc metabolic health defects across multiple generations
(Susiarjo et al. 2015). In the current study, we provide further
evidence that BPA has sex-speciﬁc eﬀects, such that the islet
function of only males is aﬀected. Additionally, we observed
dose-speciﬁc eﬀects in male oﬀspring of dams fed a lower-dose
versus a higher-dose BPA diet. We show here that the insulin se-
cretory defect in male oﬀspring is associated with impaired mito-
chondrial function in UpperB mice and reduced b-cell mass in
the LowerB mice (Table 8). It is not uncommon to ﬁnd dose-
speciﬁc eﬀects following exposure to endocrine-disrupting chem-
icals (Vandenberg et al. 2012). Various studies in the mouse have
shown that BPA aﬀects metabolism (Alonso-Magdalena et al.
2010), DNA methylation levels (Kim et al. 2014), and behavior
(Jašarević et al. 2013) in a dose-speciﬁc manner. The dose-
speciﬁc ﬁndings of the current study are consistent with these
previous studies. Uniquely, our current study shows that the
dose-speciﬁc eﬀects of BPA on the pancreas are not limited to
the ﬁrst, but are transmitted to the second generation. These per-
sistent phenotypic changes into at least the second generation are
not due to an altered metabolic milieu in the pregnant F1 female,
and thus may be transmitted through epigenetic mechanisms or
via mitochondria (Susiarjo et al. 2015). Our current ﬁndings of
persistent changes in DNA methylation at Igf2 and altered mito-
chondria function in b cells in F1 and F2 oﬀspring suggest that
both mechanisms are involved.
Mitochondrial impairment, and altered expression levels of
key mitochondrial genes such as Ucp2 and Ogdh have been previ-
ously reported in the pancreas of ﬁrst-generation adult male oﬀ-
spring of BPA-exposed rat dams (Wei et al. 2011), in isolated rat
islets (Song et al. 2012), and in BPA-exposed INS1 cells (Lin et al.
2013). Importantly, others have shown that increased Ucp2 expres-
sion increases eﬄux of acetyl-CoA–oxidizing substrates such as
a-ketoglutarate of the TCA cycle out of the mitochondria (Vozza
et al. 2014). It is known that a-ketoisocaproate promotes gluta-
mate oxidation to produce a-ketoglutarate (Zielke et al. 1997).
Therefore, the increased Ucp2 expression with an eﬄux of TCA
intermediates from the mitochondria as previously shown (Vozza
et al. 2014) suggests altered a-ketoisocaproate metabolism. Although
in the current study we observed increased Ucp2 mRNA expression
levels in BPA-exposed groups, we did not ﬁnd statistically increased
UCP2 protein levels. However, our transcriptome analysis revealed
diﬀerential expression of other genes such as Ucp2 that are also
Table 4. Genes with q<0:1 in F1 Lower BPA male vs. Control male from
RNA seq analysis. The genes that were assessed via qPCR are included in
the table (rows 10–20) for completeness.
Serial no. Gene name logFC logCPM p-Value QValue.BH
1 Lars2 −2:68 9.43 1.49E-06 0.04
2 Cth −2:81 2.43 1.60E-06 0.04
3 Klk1b22 −12:35 −0:04 8.85E-06 0.08
4 Cyp2c70 −3:67 −2:71 1.32E-05 0.08
5 Cpa5 −10:75 5.70 1.41E-05 0.08
6 Klk1b24 −5:32 1.56 1.65E-05 0.08
7 Tinag −2:48 1.01 2.22E-05 0.09
8 Reg3a −4:02 3.38 2.83E-05 0.09
9 Fgf21 −3:78 0.34 2.88E-05 0.09
10 Igf2 4.27 1.26 0.02 0.80
11 Esr1 −2:77 1.56 0.18 0.80
12 Esr2 −2:76 0.87 0.18 0.80
13 Snap25 −1:63 1.58 0.31 0.98
14 Kcnj11 −0:60 6.35 0.31 0.98
15 Ogdh 0.31 2.77 0.70 1.00
16 Abcc8 0.18 5.18 0.77 1.00
17 Pdx1 0.25 2.62 0.78 1.00
18 Igf1 0.18 2.41 0.83 1.00
19 Ucp2 −0:34 1.15 0.84 1.00
20 Hnf1a −0:09 6.06 0.86 1.00
Note: CPM, counts per million; FC, fold change. n=3 litters per group (islets pooled
from 2–3 male mice per litter).
Table 5. Genes with q<0:1 in F1 Upper BPA male vs. Control male from
RNA seq analysis. The genes that were assessed via qPCR are included in
the table (rows 42–52) for completeness.
Serial no. Gene name logFC logCPM p-Value QValue.BH
1 Lars2 −4:65 9.43 1.99E-14 4.87E-10
2 Rn45s −2:84 13.57 7.84E-10 9.59E-06
3 Dbt −3:60 3.19 3.93E-07 0.003
4 Klk1b5 −4:64 2.25 5.21E-06 0.03
5 Matn4 −1:92 9.06 7.90E-06 0.004
6 Ctnnbip1 −1:83 6.67 1.75E-05 0.007
7 Sdhc −2:06 4.94 6.00E-05 0.02
8 Spryd4 −2:34 4.13 6.11E-05 0.02
9 Chst2 −2:15 5.92 8.48E-05 0.02
10 Nccrp1 −2:27 4.16 0.0002 0.03
11 2610203C22Rik −1:83 4.51 0.0003 0.04
12 Gm5148 −1:53 10.35 0.0002 0.04
13 Zfhx2os 1.45 6.56 0.0003 0.05
14 Fam69a −1:54 8.97 0.0003 0.05
15 0610039K10Rik −1:37 9.10 0.0006 0.06
16 9530027J09Rik −0:87 7.67 0.0008 0.06
17 Casc1 −1:79 4.96 0.0005 0.06
18 Ccdc176 −1:48 7.85 0.0007 0.06
19 Ifi27l2a −1:51 4.68 0.0006 0.06
20 Loxl3 −1:16 7.96 0.0007 0.06
21 Lrrc75b −1:77 4.31 0.0007 0.06
22 Pigf −0:86 8.57 0.0007 0.06
23 4930429F24Rik 1.29 5.68 0.0009 0.06
24 Nphs1os −1:72 7.69 0.0009 0.06
25 1700028J19Rik −1:70 4.77 0.001 0.07
26 A230070E04Rik 1.45 5.51 0.001 0.07
27 Adam17 −1:30 7.30 0.002 0.08
28 Arhgap26 −1:57 4.72 0.002 0.08
29 C330022C24Rik −1:67 5.73 0.002 0.08
30 Cand2 −1:52 11.15 0.001 0.08
31 Casp9 −2:02 18.49 0.002 0.08
32 Snx22 −1:57 12.90 0.002 0.08
33 Spg11 −0:89 6.16 0.001 0.08
34 Tap2 −1:68 5.53 0.002 0.08
35 Vmn2r9 −1:62 6.12 0.002 0.08
36 Gm5088 −1:55 10.41 0.002 0.08
37 Gtf2i −2:10 4.38 0.002 0.08
38 Txnip −1:25 5.21 0.002 0.08
39 Prss57 −0:92 6.75 0.002 0.09
40 Tspan4 −0:88 6.53 0.002 0.09
41 Slc12a4 −1:78 4.98 0.002 0.09
42 Esr1 1.62 1.56 0.20 0.94
43 Abcc8 0.78 5.18 0.19 0.94
44 Igf2 1.24 1.26 0.28 0.94
45 Esr2 −1:50 0.87 0.35 0.94
46 Pdx1 0.67 2.62 0.39 0.97
47 Igf1 −0:47 2.41 0.56 1
48 Hnf1a −0:19 6.06 0.71 1
49 Snap25 0.34 1.58 0.76 1
50 Ogdh 0.16 2.77 0.83 1
51 Kcnj11 0.07 6.35 0.90 1
52 Ucp2 0.07 1.15 0.97 1
Note: CPM, counts per million; FC, fold change. n=3 litters per group (islets pooled
from 2–3 male mice per litter).
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involved in the branched-chain a-ketoacid dehydrogenase complex,
which catalyzes the metabolism of branched-chain amino acids such
as leucine and its derivative, a-ketoisocaproate. This is consistent
with a reduction in a-ketoisocaproate–stimulated insulin secretion
in the UpperB group. Therefore, it may be that genes other than
Ucp2 impair a-ketoisocaproate metabolism, consequently aﬀect-
ing a-ketoisocaproate–stimulated insulin secretion.
Reduced a-ketoisocaproate–stimulated insulin secretion and mi-
tochondrial dysfunction persisting until the second generation in
islets of the UpperB group indicate that the higher dose of BPA is
associated with mitochondrial impairment. Mitochondrial impair-
ment is associated with the production of reactive oxygen species
(ROS) such as superoxide, hydrogen peroxide, and hydroxyl radi-
cals as seen in diﬀerent type 2 diabetes models and IUGR rats
(Bindokas et al. 2003; Ihara et al. 1999; Simmons et al. 2005). ROS
can lead to the activation of NF-jB, which in turn increases pro-
inﬂammatory cytokine production (Kepp et al. 2011), eventually
leading to increased b-cell death and dysfunction. Our study
demonstrates that UpperB exposure is associated with impaired
mitochondrial function and increased pro-inﬂammatory cytokine
production. Whether this is due to oxidative stress remains to be
determined. Elevated pro-inﬂammatory cytokine levels have
been shown to induce b-cell death (Sauter et al. 2015), which in
turn reduces b-cell mass. AKT phosphorylation inhibits pro-
gramed cell death (Reed and Paternostro 1999; Yao and Cooper
1995); in the current study, increased AKT phosphorylation lev-
els and the lack of changes in cell death observed in UpperB
islets are consistent with these previous ﬁndings. The mechanism
underlying this change remains to be determined.
Despite the lack of changes in mitochondrial function in the
LowerB group, the ﬁrst- and second-generation oﬀspring of this
group had signiﬁcantly reduced b-cell function as deﬁned by
impaired insulin secretion, which suggested that a lower dose of
BPA may act via an alternate pathway in b cells, such as a reduc-
tion in b-cell mass. Impaired insulin secretion is known to be sec-
ondary to reduced b-cell mass in humans (Butler et al. 2003;
Rahier et al. 2008; Yoon et al. 2003) and animals (Bansal et al.
2015; Kjems et al. 2001; Movassat et al. 1997; Simmons et al.
2001). Indeed, we observed reduced b-cell mass adjusted for
body weight across two generations in adult male oﬀspring of
LowerB exposed dams, and these changes were associated with
increased cell death. These ﬁnding are consistent with previous
studies that reported reduced b-cell mass at birth in the oﬀspring
of rats exposed to 10 lg BPA/kg body weight per day throughout
Figure 8. Percent DNA methylation at Igf2 DMR1 and Esr1 Exon A in islets of F1 and F2 adult male oﬀspring: (A–B) F1 and (C–D) F2 adult male oﬀspring.
Data are percent CpG methylation values from individual litter (islets pooled from 2–3 males from the same litter) and presented as mean+SEM. Data were
analyzed using Dunnett’s test; p-Values are relative to Control. ** p<0:05, * p>0:05 and p<0:09.
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Figure 9. RNA Seq data in islets of F1 male mice. (A) F1 Lower BPA male vs. Control male canonical pathways from Ingenuity Pathway Analysis (IPA); IPA
parameters: 962 genes; p<0:05; inﬂammatory pathways highlighted by the rectangular box. (B) F1 Upper BPA male vs. Control male canonical Pathways
from IPA; IPA parameters: 1,275 genes; p<0:05; inﬂammatory and mitochondrial dysfunction pathways highlighted by the rectangular box. (C) Venn diagram
illustrating number of diﬀerentially expressed genes when comparing F1 Lower BPA (LowerB), Upper BPA (UpperB), and Control males; parameters: false
discovery rate (FDR) <10%, which is equivalent to p adjusted (also known as q-value) <0:1; n=3 litters (islets pooled from 2–3 males from the same litter)
per group.
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gestation and lactation (Chang et al. 2016a) and increased cell
death in BPA-exposed INS1 cells (Gong et al. 2013; Lin et al.
2013). b-cell mass was also reduced and cell death was increased
at 6 mo after delivery in female mice that were exposed to BPA
during pregnancy (Alonso-Magdalena et al. 2015a). Interestingly,
when C57BL/6 mice dams were subcutaneously injected from ei-
ther day 6 of pregnancy (P6) until birth (PND0), PND0 until
weaning (PND21), or P6-PND21 with 100 lg BPA/kg body
weight per day, b-cell mass was increased in 3-mo-old male oﬀ-
spring (Liu et al. 2013). Diﬀerences in timing, dose, route of ex-
posure, and methods of measurement of b-cell mass that were not
corrected for body weight may explain the diﬀerent results in our
study compared with those of Liu et al. (2013). In rodents, (b-cell
mass has a linear correlation with body weight such that b-cell
mass increases with body weight (Montanya et al. 2000).
Therefore, we corrected b-cell mass for body weight in our study,
so that any changes due to diﬀerence in body weight per se
would be accounted for. We chose oral BPA exposure via diet as
it has been shown to be eﬀective and a representative model of
human exposures because humans are chronically exposed to
BPA primarily through ingestion, and our doses are well within
the human exposure limits (Susiarjo et al. 2013; Sieli et al. 2011).
Importantly, end points measured in this study were from animals
generated across multiple cohorts studied in two diﬀerent animal
care facilities with a control group included in each cohort. This
reﬂects robustness of the studied outcomes and cohort consis-
tency in our paradigm.
Our study is the ﬁrst to show that developmental BPA expo-
sure induces inﬂammation in the islet in both F1 and F2 genera-
tions. Although immune cells are present in the pancreas and
play an important role in normal pancreatic development
(Criscimanna et al. 2014; Geutskens et al. 2005; Jansen et al.
1993, 1994), several studies have reported that increased cytokine
levels, and increased immune cell inﬁltration in islets, is associ-
ated with b-cell dysfunction in type 2 diabetes (Böni-Schnetzler
et al. 2008; Ehses et al. 2007; Homo-Delarche et al. 2006; Kim
et al. 2005; Lin et al. 2012; Maedler et al. 2002; Richardson et al.
2009). Increased levels of pro-inﬂammatory cytokines such as
IL6 and MCP1 reduce insulin secretion in human and mouse
islets (Sauter et al. 2015). Inﬂammatory cytokines also impair mi-
tochondria function in the b cell, which in turn blunts insulin
secretion (Gao et al. 2015). Thus, it is likely that BPA-induced is-
let inﬂammation plays a key role in the abnormal b-cell pheno-
type observed in F1 and F2 mice.
BPA is an estrogen mimic, and therefore, it is plausible that
BPA could alter Esr1 expression. In fact, maternal BPA exposure
has been shown to down-regulate Esr1 mRNA and protein
expression at P7 and P21 in the hippocampus of male rat oﬀ-
spring (Xu et al. 2014). Two injections of ICI 182,780, a brain-
permeable endoplasmic reticulum (ER) antagonist, in rat pups
were able to reverse this change, demonstrating that BPA is
causal in reducing Esr1 expression (Xu et al. 2014). Consistent
with these ﬁndings, we observed reduced Esr1 gene expression
in islets of both BPA exposure groups, and reduced ESR1 protein
levels in lower-dose exposure group. However, because BPA has
weak binding aﬃnity for estrogen receptors relative to estrogens,
it is likely that BPA mediates its eﬀect on estrogen receptor
expression without directly binding to the receptor. Other mecha-
nisms, such as a direct eﬀect on DNA methylation, may instead
be responsible for altering Esr1 gene expression as shown in the
mouse (Kundakovic et al. 2013) and rat brain (Chang et al.
2016b). We assessed DNA methylation status at 16 CpG sites in
exon A and exon C of Esr1 gene in islets, and found minimal dif-
ferences. It is possible that other gene regulatory mechanisms
such as a change in chromatin conformation may be involved.
This remains to be determined.
Estrogen receptors are widely distributed in the thymus
(Kawashima et al. 1992), bone marrow (Smithson et al. 1998),
and spleen (Samy et al. 2003), suggesting that they play a role in
regulating normal immune response. In fact, loss of Esr1 leads to
perturbed development of the thymus and spleen (Erlandsson
et al. 2001) and to altered immune responses (Douin-Echinard
et al. 2008; Lambert et al. 2005; Maret et al. 2003). Altered Esr1
expression could therefore inﬂuence the eﬀect of developmental
Table 6. Top 25 genes, by p-values, in F1 Lower BPA female vs. Control
female from RNA seq analysis.
Serial no. Gene name logFC logCPM p-Value QValue.BH
1 Creb3l3 −5:83 2.61 9.51E-05 1
2 4833419F23Rik 5.26 2.44 2.03E-04 1
3 Gm10012 −6:86 2.66 3.88E-04 1
4 Mpzl2 5.01 1.96 3.88E-04 1
5 Fam204a 5.13 2.23 7.35E-04 1
6 Krt19 −5:48 2.51 7.40E-04 1
7 Nedd9 −5:07 2.14 7.86E-04 1
8 4930470O06Rik −5:65 2.03 8.05E-04 1
9 Egr1 −4:95 2.23 9.15E-04 1
10 1700019G17Rik −5:28 2.32 0.001 1
11 Trmt5 4.89 2.24 0.001 1
12 Espl1 −5:20 2.04 0.001 1
13 St18 −5:18 2.65 0.001 1
14 Tspan2os −4:07 2.74 0.001 1
15 Drg1 −4:89 2.25 0.001 1
16 Ggta1 5.51 2.06 0.001 1
17 Fbxw7 −4:84 2.28 0.001 1
18 Serf2 −4:85 2.29 0.001 1
19 4930509J09Rik −5:05 2.40 0.001 1
20 Dhrs1 −5:02 2.21 0.001 1
21 8430437L04Rik −5:29 1.96 0.001 1
22 Rragb 4.71 2.38 0.002 1
23 Sh3bgr 4.66 1.80 0.002 1
24 Taf11 −4:86 2.12 0.002 1
25 4931431B13Rik −5:67 4.75 0.002 1
Note: CPM, counts per million; FC, fold change. n=3 litters per group (islets pooled
from 2–3 female mice per litter).
Table 7. Top 25 genes, by p-values, in F1 Upper BPA female vs. Control
female from RNA seq analysis.
Serial no. Gene name logFC logCPM p-Value QValue.BH
1 Fabp1 −9:26 5.54 4.93E-05 0.83
2 Spr 5.41 2.14 8.67E-05 0.83
3 Gda −6:75 3.71 1.82E-04 0.83
4 BC051537 3.19 5.86 2.27E-04 0.83
5 St3gal4 −5:99 3.01 2.86E-04 0.83
6 Rragb 5.26 2.38 3.79E-04 0.83
7 Wdr74 4.98 2.01 4.44E-04 0.83
8 Myo1a −7:73 4.63 4.77E-04 0.83
9 Rprm 5.64 2.26 5.47E-04 0.83
10 Pcsk5 −5:61 2.50 0.0006 0.83
11 Psmg3 −5:78 3.18 0.0006 0.83
12 Smim24 −4:89 5.48 0.0007 0.83
13 Apoa1 −6:47 5.39 0.0007 0.83
14 Rab40b 5.35 2.17 0.0007 0.83
15 Rbp2 −6:40 4.70 0.0008 0.83
16 Ephx2 −6:12 3.12 0.0009 0.83
17 Ccs −5:09 2.77 0.0009 0.83
18 Ano3 −5:57 2.56 0.0009 0.83
19 Tctn1 2.22 8.44 0.0009 0.83
20 4833419F23Rik 4.78 2.44 0.001 0.83
21 Adipor2 −3:01 3.21 0.001 0.83
22 Enpp3 −5:20 2.33 0.001 0.83
23 Slc15a1 −6:30 3.33 0.001 0.83
24 Pkdrej −3:77 2.69 0.001 0.83
25 Sis −5:91 6.32 0.001 0.83
Note: CPM, counts per million; FC, fold change. n=3 litters per group (islets pooled
from 2–3 female mice per litter).
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exposure to BPA on the pancreatic immune response, leading to
the increased inﬂammation that we observed in the islets of the
BPA-exposed animals in this study.
It is remarkable that the changes we reported in Igf2 expres-
sion and DNA methylation in the embryo persist in the islet in
adulthood and into the next generation. Further, in previous stud-
ies, the metabolic phenotypes in the F1 and F2 BPA male oﬀ-
spring were linked to Igf2 overexpression (Susiarjo et al. 2015).
Although Igf2 is protective in the adult b cell and increased
expression prevents b-cell death (Cornu et al. 2009; Hughes et al.
2013), overexpression of Igf2 in the fetus results in marked b-cell
abnormalities in fetal and adult life (Casellas et al. 2015; Höög
et al. 1996; Petrik et al. 1999). These b-cell abnormalities may
be secondary to increased islet inﬂammation because Igf2
overexpression has been reported to be associated with
increased immune cell inﬁltration in the rodent pancreas
(Casellas et al. 2015). Therefore, it is plausible to suggest that
Igf2 in combination with reduced Esr1 mediates the increased
inﬂammatory response that we observed in islets of the BPA-
exposed animals.
Finally, ingenuity pathway analysis of the RNAseq data
revealed multiple pathways that were altered and could contribute
to the abnormal pancreatic phenotype in the oﬀspring of BPA-
exposed mice, including sonic hedgehog (Shh) and gap-junction
signaling in the LowerB dose group and ER stress in the UpperB
dose group. Shh is known to play a critical role in pancreatic de-
velopment (Thomas et al. 2000), and gap junctions help establish
cross-talk within islet cells thereby regulating normal insulin
secretion and b-cell mass (Bavamian et al. 2007; Klee et al.
2011). ER stress is associated with mitochondrial dysfunction
(Rocha et al. 2016). Although we did not further interrogate these
pathways in our study, they remain important targets for future
research.
Conclusion
The current study elucidates the underlying mechanisms respon-
sible for impaired insulin secretion in mice exposed to relevant
human exposure levels of BPA during development. The persis-
tent changes in insulin secretion, mitochondria function, and
b-cell mass across multiple generations are consistent with an
epigenetically mediated mechanism. These ﬁndings have public
health ramiﬁcations and identify b-cell–specific targets of BPA
that could be used to develop potential therapeutic strategies to
prevent environment-induced diabetes.
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